Anti-Hypertensive Therapeutics Market Value in Asia-Pacific to Approach $20 Billion by 2021, Finds New Report
The anti-hypertensive therapeutics market in the Asia-Pacific (APAC) countries of Australia, India, China, and Japan will expand in value from $15.7 billion in 2014 to reach $19.9 billion by 2021, representing a Compound Annual Growth Rate (CAGR) of 3.4%, according to new report.
View full press release